Pacific Shuanglin Bio pharmacy Co Ltd (000403) — Strategic Asset Allocation Index
Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Strategic Asset Allocation Index of 21.0% as of September 2023. Strategic assets (PP&E of CN¥1.50 Billion plus long-term investments of CN¥-) total CN¥1.50 Billion, measured against net assets of CN¥7.13 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Pacific Shuanglin Bio pharmacy Co Ltd Strategic Asset Allocation Index (2000–2022)
This chart shows how Pacific Shuanglin Bio pharmacy Co Ltd's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2022. As of September 2023, the index stands at 21.0%, representing strategic assets of CN¥1.50 Billion against net assets of CN¥7.13 Billion CNY. Explore 000403 cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Pacific Shuanglin Bio pharmacy Co Ltd (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Pacific Shuanglin Bio pharmacy Co Ltd from 2000 to 2022, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 000403 market cap.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 18.9% | CN¥1.30 Billion | CN¥1.30 Billion | CN¥- | CN¥6.86 Billion | ▲ +1.5 pp |
| 2021 | 17.4% | CN¥1.10 Billion | CN¥1.10 Billion | CN¥- | CN¥6.33 Billion | ▼ -25.1 pp |
| 2020 | 42.5% | CN¥410.91 Million | CN¥410.91 Million | CN¥- | CN¥966.91 Million | ▼ -5.9 pp |
| 2019 | 48.4% | CN¥388.09 Million | CN¥388.09 Million | CN¥- | CN¥801.60 Million | ▼ -25.4 pp |
| 2018 | 73.8% | CN¥457.34 Million | CN¥457.34 Million | CN¥- | CN¥619.48 Million | ▼ -13.1 pp |
| 2017 | 86.9% | CN¥485.73 Million | CN¥485.73 Million | CN¥- | CN¥558.88 Million | ▼ -5.5 pp |
| 2016 | 92.4% | CN¥505.38 Million | CN¥505.38 Million | CN¥- | CN¥546.91 Million | ▼ -54.7 pp |
| 2015 | 147.1% | CN¥773.07 Million | CN¥773.07 Million | CN¥- | CN¥525.49 Million | ▼ -18.9 pp |
| 2014 | 166.0% | CN¥761.42 Million | CN¥761.42 Million | CN¥- | CN¥458.65 Million | ▼ -83.5 pp |
| 2013 | 249.5% | CN¥877.53 Million | CN¥877.53 Million | CN¥- | CN¥351.68 Million | ▼ -19.8 pp |
| 2012 | 269.3% | CN¥774.66 Million | CN¥774.66 Million | CN¥- | CN¥287.68 Million | ▲ +73.7 pp |
| 2011 | 195.6% | CN¥552.92 Million | CN¥552.92 Million | CN¥- | CN¥282.74 Million | ▼ -31.4 pp |
| 2010 | 226.9% | CN¥621.83 Million | CN¥621.83 Million | CN¥- | CN¥274.00 Million | ▼ -395.0 pp |
| 2009 | 622.0% | CN¥856.07 Million | CN¥856.07 Million | CN¥- | CN¥137.64 Million | ▲ +134.4 pp |
| 2008 | 487.6% | CN¥864.25 Million | CN¥864.25 Million | CN¥- | CN¥177.26 Million | ▼ -8387.7 pp |
| 2007 | 8875.3% | CN¥880.61 Million | CN¥880.61 Million | CN¥- | CN¥9.92 Million | ▲ +7743.4 pp |
| 2005 | 1131.9% | CN¥1.27 Billion | CN¥1.27 Billion | CN¥- | CN¥112.49 Million | ▲ +1026.6 pp |
| 2004 | 105.2% | CN¥633.71 Million | CN¥633.71 Million | CN¥- | CN¥602.14 Million | ▲ +28.7 pp |
| 2003 | 76.5% | CN¥643.08 Million | CN¥643.08 Million | CN¥- | CN¥840.33 Million | ▲ +27.3 pp |
| 2002 | 49.2% | CN¥383.41 Million | CN¥383.41 Million | CN¥- | CN¥779.03 Million | ▲ +2.8 pp |
| 2001 | 46.4% | CN¥319.08 Million | CN¥319.08 Million | CN¥- | CN¥687.82 Million | ▼ -1.8 pp |
| 2000 | 48.2% | CN¥288.78 Million | CN¥288.78 Million | CN¥- | CN¥599.28 Million | — |